Figure 6.
Analysis of explanted JunB transgenic and wild-type tumor cells.(A) Tumor-derived cells were subjected to a [3H]thymidine incorporation assay to investigate their proliferative potential. No difference between tumor cells from Ubi-junB transgenic and wild-type animals was observed. Data represent means ± SDs from 6 individual wells. One representative experiment is shown (n = 2). (B) Western blot analysis of JunB, p16, and actin in tumor-derived cells.